Dr. Harjivan Singh Kohli, MD

Dr. Kohli practices at Fullerton Clinical and Surgical Facility in Fullerton, California.

Dr. Kohli's NPI, 1205322393, was assigned on July 2, 2018. Dr. Kohli graduated from Oakland University William Beaumont School of Medicine in 2018. Dr. Kohli holds California license 187272.

Dr. Kohli's primary practice is Fullerton Clinical and Surgical Facility, at 301 W Bastanchury Rd, Fullerton, CA 92835 in Orange County. The practice phone is (949) 706-2887.

Dr. Kohli's primary practice is Fullerton Clinical and Surgical Facility in Fullerton, California. Dr. Kohli is also affiliated with Providence St. Jude Medical Center. The medical group on file is Southland Urology. Dmand AI also links Dr. Kohli to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kohli practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kohli's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kohli is board certified in urology by the American Board of Urology. Dmand AI has Dr. Kohli's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists enlarged prostate, prostate cancer, testicular dysfunction, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Kohli treats.

CMS data shows 1,771 Medicare services from Dr. Kohli across 20 procedure codes in 2024, for 436 Medicare patients. Medicare paid $143,664 for them.

CMS counts 436 Medicare patients who saw Dr. Kohli in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kohli's median patient age at 71, with 16% women.

In 2024, Dr. Kohli wrote 1,406 Medicare Part D claims for 514 patients. 87% of them were for generic drugs. CMS names the drug for 1,282 of them, across 19 drugs with 11 or more claims each, at $189,410 in total drug cost. In 2023, CMS named 122 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kohli for performance year 2024, reported as part of a group. Dr. Kohli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kohli as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Kohli, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Kohli, published from 2010 to 2022. The most frequent topics are Urethra. Dr. Kohli's most frequent co-authors are Brandon S. Childs, MD, Michael Joseph Ehlert, MD and Natalie P. Gaines, MD.

CMS Open Payments shows 25 general payments to Dr. Kohli from 10 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 47% of the total. Intuitive Surgical, Inc. paid the most, $1,296.

Dmand AI lists 1 award for Dr. Kohli, most recently Alpha Omega Alpha Honor Society in 2018.

Dr. Kohli graduated from Oakland University William Beaumont School of Medicine in 2018.

Dr. Kohli is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.